Greenline Partners’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.34M | Hold |
3,813
| – | – | 0.14% | 89 |
|
|
2025
Q4 | $1.25M | Hold |
3,813
| – | – | 0.14% | 94 |
|
|
2025
Q3 | $1.08M | Sell |
3,813
-1,116
| -23% | -$324K | 0.13% | 92 |
|
|
2025
Q2 | $1.38M | Sell |
4,929
-7,417
| -60% | -$2.1M | 0.19% | 85 |
|
|
2025
Q1 | $3.85M | Sell |
12,346
-3,209
| -21% | -$948K | 0.56% | 46 |
|
|
2024
Q4 | $4.05M | Hold |
15,555
| – | – | 0.57% | 50 |
|
|
2024
Q3 | $5.01M | Hold |
15,555
| – | – | 0.72% | 33 |
|
|
2024
Q2 | $4.84M | Sell |
15,555
-3,339
| -18% | -$981K | 0.74% | 34 |
|
|
2024
Q1 | $5.37M | Hold |
18,894
| – | – | 0.86% | 31 |
|
|
2023
Q4 | $5.44M | Hold |
18,894
| – | – | 0.92% | 29 |
|
|
2023
Q3 | $5.08M | Hold |
18,894
| – | – | 0.96% | 30 |
|
|
2023
Q2 | $4.19M | Sell |
18,894
-136
| -0.7% | -$31.6K | 0.78% | 34 |
|
|
2023
Q1 | $4.6M | Hold |
19,030
| – | – | 0.88% | 31 |
|
|
2022
Q4 | $5M | Hold |
19,030
| – | – | 0.99% | 33 |
|
|
2022
Q3 | $4.29M | Hold |
19,030
| – | – | 0.98% | 33 |
|
|
2022
Q2 | $4.63M | Hold |
19,030
| – | – | 1% | 30 |
|
|
2022
Q1 | $4.6M | Sell |
19,030
-311
| -2% | -$71.5K | 0.86% | 37 |
|
|
2021
Q4 | $4.35M | Hold |
19,341
| – | – | 0.82% | 36 |
|
|
2021
Q3 | $4.11M | Hold |
19,341
| – | – | 0.86% | 35 |
|
|
2021
Q2 | $4.71M | Sell |
19,341
-717
| -4% | -$176K | 0.96% | 27 |
|
|
2021
Q1 | $4.99M | Hold |
20,058
| – | – | 1.09% | 25 |
|
|
2020
Q4 | $4.61M | Buy |
20,058
+1,986
| +11% | +$458K | 1.06% | 27 |
|
|
2020
Q3 | $4.59M | Buy |
18,072
+11,879
| +192% | +$2.94M | 1.17% | 28 |
|
|
2020
Q2 | $1.46M | Sell |
6,193
-788
| -11% | -$180K | 0.39% | 57 |
|
|
2020
Q1 | $1.42M | Sell |
6,981
-737
| -10% | -$161K | 0.46% | 64 |
|
|
2019
Q4 | $1.86M | Sell |
7,718
-1,249
| -14% | -$275K | 0.47% | 56 |
|
|
2019
Q3 | $1.74M | Buy |
8,967
+75
| +0.8% | +$14.4K | 0.5% | 51 |
|
|
2019
Q2 | $1.64M | Sell |
8,892
-11,950
| -57% | -$2.14M | 0.52% | 45 |
|
|
2019
Q1 | $3.96M | Sell |
20,842
-24,956
| -54% | -$4.77M | 1.3% | 33 |
|
|
2018
Q4 | $9.55M | Hold |
45,798
| – | – | 2.99% | 11 |
|
|
2018
Q3 | $9.55M | Sell |
45,798
-1,259
| -3% | -$248K | 2.99% | 11 |
|
|
2018
Q2 | $8.68M | Buy |
47,057
+2,014
| +4% | +$356K | 2.84% | 14 |
|
|
2018
Q1 | $7.68M | Buy |
45,043
+1,802
| +4% | +$331K | 2.55% | 17 |
|
|
2017
Q4 | $7.52M | Buy |
+43,241
| New | +$7.65M | 2.5% | 19 |
|
Other funds holding AMGN
VCM
VPM
Greenline Partners's AMGN Position: Q1 2026 in Review
Greenline Partners held its Amgen (AMGN) position steady in Q1 2026 at 3,813 shares worth $1.34M. The position accounts for 0.14% of the portfolio, ranked #89.
Greenline Partners first reported a position in AMGN in Q4 2017 and has held it in 34 quarters since. The position peaked at $9.55M in Q4 2018. 3,126 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Greenline Partners held 3,813 shares of Amgen worth $1.34M as of Q1 2026.
- Greenline Partners left its Amgen share count unchanged in Q1 2026.
- Amgen made up 0.14% of Greenline Partners's portfolio in Q1 2026, its #89 holding.
- Greenline Partners first reported a position in Amgen in Q4 2017 and has held it in 34 quarters since.
- Greenline Partners's Amgen position peaked at $9.55M in Q4 2018.
- 3,126 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Greenline Partners's 13F filing for Q1 2026, filed 15 May 2026.